Oettgen H F
Memorial Sloan-Kettering Cancer Center, New York.
Curr Opin Immunol. 1991 Oct;3(5):699-705. doi: 10.1016/0952-7915(91)90099-m.
Cytokines have been of much interest in clinical cancer therapy research over the past decade. One important advance during the past year has been the clear demonstration, in large prospective randomized studies, that granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor reduce the neutropenia-related morbidity of cancer therapy.
在过去十年中，细胞因子一直是临床癌症治疗研究的热点。过去一年的一项重要进展是，在大型前瞻性随机研究中明确证实，粒细胞集落刺激因子和粒细胞巨噬细胞集落刺激因子可降低癌症治疗中与中性粒细胞减少相关的发病率。
